Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJB6E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,757
Award facts
- Contract value 100% obligated
- $8,756.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a ceiling value of $8,756.64 and a completion date of December 2, 2025. This competitive, non-set-aside delivery order reflects the company's role as a critical pharmaceutical supplier within the federal medical procurement system. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle that extends through December 2026 and enables the company to supply an extensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Dupixent, a specialty pharmaceutical treatment, exemplifies the company's capability to fulfill federal medical supply needs through open competition and firm fixed pricing arrangements.
Quick answers
Who was awarded contract SPE2DR26FJB6E?
SPE2DR26FJB6E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FJB6E worth?
The government has obligated $8,757 on SPE2DR26FJB6E.
Is contract SPE2DR26FJB6E an order under another contract?
Yes. SPE2DR26FJB6E is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJB6E competed?
The extent of competition for SPE2DR26FJB6E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award